Results 181 to 190 of about 2,827,583 (304)

Procalcitonin in patients undergoing chronic hemodialysis [PDF]

, 2000
Schmidt, Martin, Sitter, Thomas, Schiffl, Helmut, Burchardi, Christian, Held, Eckhard   +4 more
core   +1 more source

Protective Effect of Phytic Acid in Cardiovascular Diseases: A Systematic Review

ChemFoodChem, Volume 2, Issue 3, September 2026.
ABSTRACT Cardiovascular diseases (CVDs) are a cluster of ailments that impact the heart and blood vessels and are a primary public health problem of mortality on a global scale. Phytic acid, a dietary constituent frequently present in foods like seeds, has been linked to many pharmacological attributes, including anti‐cancer, antioxidant, anti ...
Marta M. S. de Freitas Almeida, Éverton A. Pereira, Patricia Severino, Cristina Blanco‐Llamero, Sandra L. Santos, Luciana N. Andrade, Ricardo G. Amaral, Eliana B. Souto   +7 more
wiley   +1 more source

Daily Hemodialysis

Jinko Zoki, 1999
openaire   +1 more source

Medication belief profiles and associated factors in patients receiving maintenance hemodialysis: a latent class analysis. [PDF]

Front Public Health
Yang F, Zhong Y, Zeng L, Yuan Z, Zhou Y, Tian Y.   +5 more
europepmc   +1 more source

Long‐Term Renal Function and Clinical Outcomes of Sacubitril/Valsartan in HFrEF and Stage 3–4 Chronic Kidney Disease: A 24‐Month Single‐Centre Cohort

Clinical Cardiology, Volume 49, Issue 9, September 2026.
In this 24‐month, single‐centre cohort of 360 patients with HFrEF and stage 3–4 chronic kidney disease, sacubitril/valsartan was well tolerated, with stable renal function, improved symptoms, and low rates of renal events and mortality. These descriptive findings are hypothesis‐generating and warrant confirmation in controlled studies.
Fatih Akkaya, Onur Osman Şeker, Ercan Türkmen, Seçkin Dereli   +3 more
wiley   +1 more source

A Mobile-Based Mindfulness Intervention for Reducing Demoralization in Patients on Maintenance Hemodialysis: Randomized Controlled Trial. [PDF]

J Med Internet Res
Shen X, Li H, Sun F, Gu M, Zhang H, Zhu F.   +5 more
europepmc   +1 more source

Release of Granulocyte Proteinases during Hemodialysis [PDF]

, 1983
Hörl, H., Heidland, August, Jochum, Marianne, Fritz, Hans   +3 more
core   +1 more source

A Clinically Aligned Two‐Stage Machine Learning Framework for Predicting Hungry Bone Syndrome After Parathyroidectomy

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
A clinically aligned two‐stage machine learning framework integrates preoperative and perioperative features to predict hungry bone syndrome after parathyroidectomy. Explainable risk stratification may support individualised calcium management and early intervention for high‐risk patients.
Shih‐Min Yin, Yu‐Chieh Lin, Tzu‐Hsun Hung, Shen‐En Chou, Shun‐Yu Chi, Fong‐Fu Chou, Yi‐Ju Wu, Si‐Yuan Wu, Jenn‐Jier James Lien, Po‐Chih Kuo, Yi‐Chia Chan   +10 more
wiley   +1 more source

No Boundaries for TAVI? Balancing Feasibility of TAVI in Hemodialysis Patients With Prognostic Value of Comorbidities. [PDF]

JACC Asia
Bekeredjian R.
europepmc   +1 more source

Therapeutic Effects of Propolis Supplementation on the Inflammatory State, Oxidative Stress, and Uremic Toxins in dialysis Patients: A Systematic Review

Food Science &Nutrition, Volume 14, Issue 9, September 2026.
This systematic review of 6 clinical trials (n = 225) demonstrates that Propolis supplementation (200–400 mg/day for 2–6 months) significantly reduces key inflammatory cytokines TNF‐α, IL‐8, IL‐17, IFN‐γ, and oxidative stress (oxLDL) in dialysis patients.
Mahshid Mardani, Alireza Ostadrahimi, Azizeh Farshbaf‐Khalili   +2 more
wiley   +1 more source